Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
ONCOLYTICS BIOTECH INC (ONCY)
Standardized SEC financial data for ONCOLYTICS BIOTECH INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001129928 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-530.0%
Income statement
C$
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
R&D expense
C$12.9M
C$12.9M
C$15.4M
C$17.7M
C$21.6M
—
SG&A expense
C$12.5M
C$13.3M
C$11.5M
C$16.1M
C$13.3M
—
Net income
-C$22.5M
-C$26.3M
-C$24.8M
-C$27.8M
-C$31.7M
—
Standardized from ONCOLYTICS BIOTECH INC's SEC filings — per-share figures split-adjusted. Full history via the API.